Diabetes treatment depends on the type of diabetes the patient is diagnosed with. Type I diabetes generally is diagnosed at a younger age, and occurs when the body is unable to produce insulin naturally. Insulin is essential in aiding the body’s ability to move energy resources in the form of glucose from the blood stream into the cells that need it. Type II diabetes, on the other hand, occurs when some insulin can be manufactured naturally, but it is not as efficient as it should be in transporting glucose to the cells. This often results in dangerously high blood sugar levels.

Diabetes treatment for each type is different. Diabetes treatment for Type I generally involves a combination of dietary modifications, a prescribed exercise regimen, and insulin replacement therapy. Diabetes treatment for type II is treated with a medically-supervised course of weight reduction, followed by institution of a diabetic diet and exercise regimen. Only if these measures fail does treatment then include oral or injected insulin replacement therapy. There are several medications available for diabetes treatment of Type II, which perform one or several functions including boosting the pancreas’ ability to produce insulin, and reducing the liver’s glucose output function.

According to the Center for Disease Control (CDC), approximately 7.8 percent of the population currently suffers from some form of diabetes, a metabolic disorder that affects how the body processes glucose. Glucose, a simple sugar, is a primary means by which the body receives nutrients. The body breaks down glucose primarily through the help of insulin, which is produced by the pancreas. When insulin is not present at sufficient levels to assist with metabolizing glucose, the body system becomes toxic and organ damage or failure as well as vision loss and blindness, called retinopathy, can occur. The good news is that both conditions are treatable if caught early.

Diabetes treatment focuses on keeping blood glucose levels within manageable, non-toxic levels. Following diagnosis confirmation, consistent management through diabetes treatment is key to restoring proper organ functionality and preventing the onset of blindness. In addition to preventative measures such as moderating diet and blood glucose levels and getting adequate exercise, as well as regularly prescribed treatment protocols dialysis and injectible insulin, a federally-funded study called the Diabetes Prevention Program (DPP) paved the way for exciting new clinical trials that offer new hope for a new wave of future diabetes treatment options.

For those suffering from diabetes, one of the best ways to take control of the disease and make a difference in finding a permanent cure is to enroll in a clinical trial.

If you are located in the Florida area, for example, one of the most popular locations to find diabetes trials in Orlando. The city has a large population and an aggressive research and technology sector which offers a range of clinical trial options.

When searching out diabetes trials in Orlando, there are a few key points to bear in mind. First, make sure to contact a reputable firm. Avail Clinical Research, as an example, is not only partnered with several major international prescription drug companies, but has received significant support from the county of Volusia to continue their work.

Diabetes trials in Orlando can take many forms and test many different facets of the disease, and is worth knowing that the company running the trial is not only local, but has the support of both local government agencies and the backing of big players in the industry.

By using caution and care when looking for diabetes trials in Orlando, patients can find a great experience and help the cause simultaneously.

A recent New York Times article cites an alarming new Centers for Disease Control and Prevention survey that found the country’s obesity rate to be growing at a sobering rate. Americans’ waistlines in the South in particular are bulging ever outward. Given the established causal link between obesity and diabetes, this is also disturbing for our ongoing fight against diabetes. There’s no time like the present to consider participating in a diabetes trial Orlando. New diabetes treatments may help us all understand the condition.

The survey found an obesity rate exceeding thirty percent in nine states (Alabama, Arkansas, Kentucky, Louisiana, Mississippi, Missouri, Oklahoma, Tennessee and West Virginia, with Mississippi topping all), where three years ago, only three states earned that distinction. That translates to almost three million more obese Americans than in 2007, bringing the total number to right around 73 million. Taking into account this survey was self-reported over the phone, odds are this number is probably a little light. (“Obese” as defined by the CDCP would translate to a woman 5’4” and 174lbs. or a man 5’10” and 209lbs.) There is small reason to think these numbers won’t worsen in the next three years.

Once again, we’re reminded just how serious the growing threat of both obesity and diabetes is to Americans (and by extension, the American healthcare system).

Studies have long suggested a strong causal link between obesity and type 2 diabetes. Now some doctors are reversing that relationship to control diabetes by using weight reduction surgery. It’s like putting the chicken back into the egg by sterilizing the chicken—and it is working.

Some studies have shown that gastric banding and stomach stapling—both intended to make the stomach smaller, giving the sensation of a “full stomach” with much less food, leading to a reduction in caloric intake—has restored blood sugar levels to normal in obese Type 2 diabetics. These procedures are safe, approved weight reduction methods typically prescribed only when the patient is classified as obese according to federal health guidelines.

While these procedures have proven effective when used with obese patients, some doctors now believe that they will prove an effective and economical diabetes treatment for patients classed merely as overweight. The cost-benefit analysis strongly favors the expensive but permanent weight-reduction surgery over the lifetime costs of conventional diabetes management methods (drugs, insulin, constant testing). Doctors are now recruiting for studies to evaluate the viability of these procedures as a diabetes management tools.